Trifluridine (also called trifluorothymidine or TFT) is an anti-herpesvirus antiviral drug, used primarily on the eye. It was sold under the trade name, Viroptic, by Glaxo Wellcome, now merged into GlaxoSmithKline. The brand is now owned by Monarch Pharmaceuticals, which is wholly owned by King Pharmaceuticals. It is a nucleoside analogue, a modified form of deoxyuridine, similar enough to be incorporated into viral DNA replication, but the -CF3 group added to the uracil component blocks base pairing. It is a component of the experimental anti-cancer drug TAS-102.
Fernandez-Lucas, Jesus; Fresco-Taboada, Alba; Acebal, Carmen; Mata, Isabel; Arroyo, Miguel. Applied Microbiology and Biotechnology. Enzymatic synthesis of nucleoside analogues using immobilized 2'-deoxyribosyltransferase from Lactobacillus reuteriVolume. 91. Issue 2. Pages 317-327. Journal; Online Computer File (2011)
No Data
No Data
Komatsu, Hironori; Umetani, Hideki. Organic Process Research & Development. Synthesis of Trifluorothymidine: Green Glycosylation Condition Using Neither Chloroform nor Transition Metals. Volume 6. Issue 6. Pages 847-850. Journal. (2002)
No Data
No Data
Ji, Yining; Brueckl, Tobias; Baxter, Ryan D.; Fujiwara, Yuta; Seiple, Ian B.; Su, Shun; Blackmond, Donna G.; Baran, Phil S. Innate C-H trifluoromethylation of heterocycles. Proceedings of the National Academy of Sciences of the United States of America. Volume 108. Issue 35. Pages 14411-14415. 2011.
Fang, Zhongxue; Ning, Yongquan; Mi, Pengbing; Liao, Peiqiu; Bi, Xihe. Catalytic C-H α-Trifluoromethylation of α,β-Unsaturated Carbonyl Compounds. Organic Letters. Volume 16. Issue 5. Pages 1522-1525. 2014
Kumar, Vineet; Malhotra, Sanjay V. Synthesis of nucleoside-based antiviral drugs in ionic liquids. Bioorganic & Medicinal Chemistry Letters. Volume 18. Issue 20. Pages 5640-5642. 2008.
Yang, Binghui; Qiu, Jingang; Ling, Guochang. Method for preparation of 5-trifluoromethyl-2'-deoxyuridine. Assignee Hangzhou Fubang Biological Pharmacy Co., Ltd., Peop. Rep. China. CN 1640882 A (2005).
